Search

everythinglearnresearchcommunity

for

Search:↓

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

A woman had high testosterone due to an ovarian issue, which was fixed with surgery.

Young women with PCOS and no other heart risk factors have normal heart function.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Finasteride effectively reduces excess hair in women with certain conditions.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Relatives of women with PCOS symptoms are more likely to have similar health issues.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

Certain gene variations are found in people with polycystic ovary syndrome.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Low leptin levels in obese women with high testosterone may indicate a tumor that secretes male hormones.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Bacterial vaginosis is not linked to skin disorders in these patients.